AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dashglim-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Dashak Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Dashglim-M1 Tablet SR

Diabetam Duo SR tablets are a dual-action antidiabetic medication for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabetam Duo SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of complications such as kidney problems, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize its symptoms (sweating, dizziness, headache, trembling) and how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic effect. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before starting treatment; it may not be appropriate. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood sugar monitoring and periodic blood tests (blood cell count, liver function) may be recommended by your physician.

Primary Ingredients of Dashglim-M1 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Dashglim-M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Dashglim-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Dashglim-M1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be administered with food.

Common Side effects of Dashglim-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dashglim-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dashglim-M1 Tablet SR should be administered with a meal.

How Dashglim-M1 Tablet SR works:

Dashglim-M1 SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Dashglim-M1 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dashglim-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Dashglim-M1 tablets are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Exercise caution when administering Dashglim-M1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Avoid prescribing Dashglim-M1 Tablet SR to patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Dashglim-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiate treatment with a low Dashglim-M1 Tablet SR dose; however, it's contraindicated in severe liver disease.

What if you forget to take Dashglim-M1 Tablet SR :

Should you forget to take a Dashglim-M1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dashglim-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Dashglim-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Dashglim-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Dashglim-M1 Tablet SR and seek immediate medical attention.
Dashglim-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Dashglim-M1 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Dashglim-M1 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Dashglim-M1 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dashglim-M1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dashglim-M1 Tablet SR
56
MRP 65
13% off